MedPath

Evaluation of the Child/Adolescent and Parent Emotion Regulation (CAPER) Program for At-Risk Youth

Not Applicable
Conditions
emotion regulation difficulties
Mental Health - Other mental health disorders
Registration Number
ACTRN12617001220358
Lead Sponsor
Macquarie University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

1) Child must be aged 6 to 14 years of age
2) Child has demonstrated emotion regulation difficulties on a regular basis over the past 4 weeks (e.g., acting out, struggling to manage or expressive emotions)
3) Is able to speak and understand English
4) At least one parent/caregiver is committed to attending the therapy sessions in conjunction with the child.

Exclusion Criteria

(1) Meets full diagnostic criteria for any psychiatric disorder
(2) Current suicidal ideation or self harm behaviours.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Emotional Awareness Questionnaire (Child)<br><br><br><br>[Baseline (T1)<br>Time 2 (T2) - 3 weeks follow-up baseline (T1) and prior to commencing the therapy program <br>Time 3(T3) - end of therapy<br>Time 4 (T4) - 1-month follow-up];Emotion Regulation Questionnaire (Child and Adult versions)<br>[NB - Both children and adults will be asked to complete the appropriate version of this measure][Baseline (T1)<br>Time 2 (T2) - 3 weeks follow-up baseline (T1) and prior to commencing the therapy program <br>Time 3(T3) - end of therapy<br>Time 4 (T4) - 1-month follow-up];Cognitive Emotion Regulation Questionnaire (CERQ-18) (child and adult versions)<br>[NB - Both children and adults will be asked to complete the appropriate version of this measure][Baseline (T1)<br>Time 2 (T2) - 3 weeks follow-up baseline (T1) and prior to commencing the therapy program <br>Time 3(T3) - end of therapy<br>Time 4 (T4) - 1-month follow-up]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath